Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
0.2574 USD -1.11% Intraday chart for GlycoMimetics, Inc. -5.02% -89.09%
Jun. 04 Transcript : GlycoMimetics, Inc. - Special Call
Jun. 04 GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GLYCOMIMETICS, INC.
Bio Therapeutic Drugs
-1.11%-5.02%-89.09%-85.86%-97.80% 16.59M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Charts GlycoMimetics, Inc.
  5. Relative Strength Chart